Ohio's Proposed Ban On Sales Marks Kratom Industry's Latest Battlefront

摘要

Ohio Board of Pharmacy proposes placing into Schedule I kratom constituent ingredients mitragynine and 7- hydroxymitragynine, a change that would prohibit kratom sales in the state. The board's findings "parrot the false propaganda" of FDA in its "crusade to ban kratom," says the American Kratom Association.